Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about GLP/1 drugs
Recent news which mentions GLP/1 drugs
Novo Nordisk Surges On Wegovy Win, Eyes Bullish Rebound Near 52-Week Lows
August 18, 2025
Tickers
NVO
Tags
NVO
Benzinga
Top Stories
From
Benzinga
Eli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan
March 07, 2025
Tickers
AMZN
GLP
LLY
TDOC
Tags
General
Biotech
Analyst Color
From
Benzinga
Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?
November 05, 2024
Tickers
ASND
NVO
Tags
NVO
Trading Ideas
glp/1
From
Benzinga
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
October 22, 2024
Tickers
LLY
NVO
PFE
VKTX
Tags
VKTX
Previews
Biotech
From
Benzinga
Hims & Hers Health Stock Is Popping Monday: What's Behind The Move?
October 14, 2024
Tickers
HIMS
LLY
NEWS
NVO
Tags
Market News
LLY
why it's moving
From
Benzinga
Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan
September 11, 2024
Tickers
VKTX
Tags
GLP/1 drugs
obesity drug
Expert Ideas
From
Benzinga
Bernie Sanders: 'Ozempic Will Likely Become One Of The Best-Selling Pharmaceutical Products In History' — Americans Shouldn't Pay 10-15X More
June 26, 2024
Tickers
GLP
NEWS
NVO
Tags
Sanders
General
NVO
From
Benzinga
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
May 30, 2024
Tickers
LLY
NVO
OZEM
Tags
ETFs
Biotech
NVO
From
Benzinga
Mangoceuticals Develops Oral GLP-1s: Stock Soars
May 21, 2024
Tickers
MGRX
NEWS
Tags
Benzinga
Movers
News
From
Benzinga
Two Big Upside Risks To Watch
March 04, 2024
Tickers
AI
Tags
Benzinga
Market News
contributors
From
Benzinga
Goldman Sachs: Eli Lilly's Shares May Surge By 140% With GLP-1 Drug Boom
December 19, 2023
Tickers
LLY
Tags
Eli Lilly & Co/
Benzinga
Analyst Ratings
From
Benzinga
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
December 08, 2023
Tickers
ALT
LLY
NVO
PFE
Tags
Mounjaro
NVO
Ozempic
From
Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
Tickers
LLY
NVO
RHHBY
Tags
Ozempic
Benzinga
weight loss drugs
From
Benzinga
Wegovy, Ozempic Could Save 139,400 Lives In US Each Year; Novo Nordisk Heart Attack Research Reveals New Benefits
August 08, 2023
Tickers
LLY
NVO
Tags
Ozempic
Benzinga
Mounjaro
From
Benzinga
As Drugs Like Ozempic And Mounjaro Disrupt The Weigh Loss Market, Who Stands To Win — And Who Stands To Lose?
April 18, 2023
Tickers
LLY
NVO
PLNT
PTON
Tags
wegovy
WW
GLP/1 drugs
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today